139 related articles for article (PubMed ID: 17067434)
1. Anti-Saccharomyces cerevisiae antibodies in Behçet's disease--a familial study.
Monselise A; Weinberger A; Monselise Y; Fraser A; Sulkes J; Krause I
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S87-90. PubMed ID: 17067434
[TBL] [Abstract][Full Text] [Related]
2. Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease.
Krause I; Monselise Y; Milo G; Weinberger A
Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S21-4. PubMed ID: 12371630
[TBL] [Abstract][Full Text] [Related]
3. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome.
Fresko I; Ugurlu S; Ozbakir F; Celik A; Yurdakul S; Hamuryudan V; Yazici H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S67-70. PubMed ID: 16273768
[TBL] [Abstract][Full Text] [Related]
4. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of anti-
Cheng L; Li L; Liu C; Yan S; Li Y
BMJ Open; 2020 Oct; 10(10):e033880. PubMed ID: 33028542
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
Riente L; Chimenti D; Pratesi F; Delle Sedie A; Tommasi S; Tommasi C; Bombardieri S; Migliorini P
J Rheumatol; 2004 May; 31(5):920-4. PubMed ID: 15124251
[TBL] [Abstract][Full Text] [Related]
7. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
8. IgG subclasses of anti Saccharomyces cerevisiae antibody in inflammatory bowel disease.
Oshitani N; Hato F; Jinno Y; Sawa Y; Nakamura S; Matsumoto T; Seki S; Kitagawa S; Arakawa T
Eur J Clin Invest; 2001 Mar; 31(3):221-5. PubMed ID: 11264649
[TBL] [Abstract][Full Text] [Related]
9. Anti-Saccharomyces cerevisiae antibodies are elevated in Graves' disease but not in Hashimoto's thyroiditis.
Mankaï A; Thabet Y; Manoubi W; Achour A; Sakly W; Ghedira I
Endocr Res; 2013; 38(2):98-104. PubMed ID: 22992126
[TBL] [Abstract][Full Text] [Related]
10. Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease.
Van Kemseke C; Belaïche J; Steeman C; Louis E
Acta Gastroenterol Belg; 2003; 66(1):1-6. PubMed ID: 12812142
[TBL] [Abstract][Full Text] [Related]
11. Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction.
Cinemre H; Bilir C; Gokosmanoglu F; Kadakal F
J Investig Med; 2007 Dec; 55(8):444-9. PubMed ID: 18163971
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae antibodies in coeliac disease.
Toumi D; Mankaï A; Belhadj R; Ghedira-Besbes L; Jeddi M; Ghedira I
Scand J Gastroenterol; 2007 Jul; 42(7):821-6. PubMed ID: 17558905
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease.
Zhang S; Luo J; Wu Z; Roggenbuck D; Schierack P; Reinhold D; Li J; Zeng X; Zhang F; Qian J; Li Y
Clin Transl Gastroenterol; 2018 Feb; 9(2):e133. PubMed ID: 29446764
[TBL] [Abstract][Full Text] [Related]
14. Serum anti-Saccharomyces cerevisiae antibodies in Greek patients with Behcet's disease.
Vaiopoulos G; Lakatos PL; Papp M; Kaklamanis F; Economou E; Zevgolis V; Sourdis J; Konstantopoulos K
Yonsei Med J; 2011 Mar; 52(2):347-50. PubMed ID: 21319357
[TBL] [Abstract][Full Text] [Related]
15. ASCA (Anti-Saccharomyces cerevisiae Antibody) in Patients With Scleroderma.
Fedrigo A; Skare TL; Bortoluzzi AL; Nisihara R
J Clin Rheumatol; 2019 Jan; 25(1):24-27. PubMed ID: 29561467
[TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus.
Mankaï A; Sakly W; Thabet Y; Achour A; Manoubi W; Ghedira I
Rheumatol Int; 2013 Mar; 33(3):665-9. PubMed ID: 22527140
[TBL] [Abstract][Full Text] [Related]
17. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
18. Anti Saccharomyces cerevisiae Antibodies in Patients With Anti-β2 Glycoprotein I Antibodies.
Mankaï A; Layouni S; Ghedira I
J Clin Lab Anal; 2016 Nov; 30(6):818-822. PubMed ID: 27061484
[TBL] [Abstract][Full Text] [Related]
19. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS
Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284
[TBL] [Abstract][Full Text] [Related]
20. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients.
Amre DK; Lu SE; Costea F; Seidman EG
Am J Gastroenterol; 2006 Mar; 101(3):645-52. PubMed ID: 16464223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
